Revolution Medicines (RVMD) Amortization of Deferred Charges (2020 - 2026)
Revolution Medicines' quarterly Amortization of Deferred Charges came in at $12.2 million in Q1 2026, up 2.18% quarter-over-quarter from $11.9 million in Q4 2025.
Revolution Medicines has reported Amortization of Deferred Charges for 4 years, with the latest figure at $12.2 million in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges changed N/A year-over-year to $12.2 million; the trailing twelve-month figure through Mar 2026 stood at $36.4 million (up 3620.94% YoY), and the FY2025 full-year result was $24.2 million, changed N/A from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $12.2 million, up from $11.9 million in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $12.2 million in Q1 2026, with the low at $866000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.20 Mn |
| Mar 31, 2026 | 12.20 Mn |
| Dec 31, 2025 | 11.94 Mn |
| Dec 31, 2025 | 11.94 Mn |
| Sep 30, 2025 | 11.43 Mn |
| Sep 30, 2025 | 11.43 Mn |
| Jun 30, 2025 | 866,000.00 |
| Jun 30, 2025 | 866,000.00 |
| Dec 31, 2021 | 979,000.00 |
| Dec 31, 2021 | 979,000.00 |
| Sep 30, 2021 | 691,000.00 |
| Sep 30, 2021 | 691,000.00 |
| Jun 30, 2021 | 770,000.00 |
| Jun 30, 2021 | 770,000.00 |
| Mar 31, 2021 | 740,000.00 |
| Mar 31, 2021 | 740,000.00 |
| Dec 31, 2020 | 759,000.00 |
| Dec 31, 2020 | 759,000.00 |
| Sep 30, 2020 | 698,000.00 |
| Sep 30, 2020 | 698,000.00 |
| Jun 30, 2020 | 764,000.00 |
| Jun 30, 2020 | 764,000.00 |
| Mar 31, 2020 | 645,000.00 |
| Mar 31, 2020 | 645,000.00 |